Skip to content

Inflammation and complications after pulmonary surgery for cancer

Inflammation and complications after pulmonary surgery for cancer - ICAPSUC

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46474
Enrollment
250
Registered
2018-04-23
Start date
2018-11-12
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperatieve complicaties complication complications after lung surgery postoperative outcome

Interventions

None listed

Sponsors

Amphia Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Elective pulmonary surgery (pneumonectomy, (bi)(sleeve)lobectomy, segmentectomy) for cancer, American Society of Anesthesiologists (ASA) physical status classification >=2 with a planned postoperative admission to the Intensive Care.

Exclusion criteria

Exclusion criteria: (suspected) Infection at the time of surgery and reoperation within 24 hours of surgery

Design outcomes

Primary

MeasureTime frame
Main study parameters are levels of IL-6, CRP, leucocyte count, PCT, ntproBNP, GDF-15 and hs-cTn. Primary endpoint is the development of an infectious complication which is defined as one of the following outcomes within 30 days of surgery: - pneumonia (purulent sputum, positive sputum or blood culture and clinical symptoms such as cough, fever or consolidation on chest radiograph) - pulmonary empyema (pleural effusion and the presence of pus on pleural aspiration, microorganism on pleural fluid culture or positive pleural fluid Gram stain) - sepsis (qSOFA score >=2 in response to an infection) - wound infection (purulent drainage from superficial incision or deliberate opening of superficial incision by surgeon and pain, tenderness, swelling or redness) - urinary tract infection (urinary tract symptoms or fever and urine culture with no more than 2 species of organisms identified with at least one of which is a bacterium of >=105 CFU/ml)

Secondary

MeasureTime frame
Secondary endpoint is the development of a non-infectious complication which is defined as one of the following outcomes within 30 days of surgery: - acute kidney injury (increase in serum creatinine by >= 26 µmol/l, a percentage increase in serum creatinine of more than or equal to 50% or oliguria of less than 0.5 ml/kg per hour for more than six hours within 48 hours) - respiratory insufficiency (hypoxia or hypercapnia leading to ICU (re)admission) - reoperation - supraventricular arrhythmia (new-onset atrial fibrillation or atrial flutter) - congestive heart failure (pleural effusion or pulmonary edema requiring diuretic therapy) - acute respiratory distress syndrome (defined as diffuse inflammatory lung injury (onset over 1 week or less), bilateral opacities consistent with pulmonary edema must be present and may be detected on CT or chest radiograph, PF ratio = 75% in a pulmonary artery with corresponding normal ventilation - stroke (clinical diagnosis of acute transient ischemic attack (TIA) or cerebrovascular accident (CVA)) - myocardial infarction (elevated hs-cTn in combination with clinical symptoms or electrocardiography changes) - mortality Other secondary endpoints that will be captured are any complication (which is a composite of infectious and non-infectious complications within 30 days of surgery), length of ICU stay and length of hospital stay. For both the primary and secondary endpoints the exact time (in hours and days after surgery, and during or after ICU admission) on which the endpoint is reached will be noted.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)